NCT06853847

Brief Summary

Today, complementary and alternative treatments are frequently used to maintain health and well-being, reduce symptoms of diseases, and provide relaxation. Nurses contribute to the healing process by using pharmacological and nonpharmacological methods. Pharmacological methods cause nausea, vomiting, respiratory depression, gastrointestinal and urinary system complications in individuals. Therefore, nonpharmacological methods without side effects are gaining importance. Nonpharmacological methods are easy and simple nursing interventions that do not have side effects, are cost-effective, can be easily taught to the patient, reduce pain and anxiety. They can also be used in addition to pharmacological methods and are preferred in patients who do not take medication or are unwilling to take medication. Providing a safe position without vascular complications and back pain after the procedure is very important for both the patient and the nurse who cares for the patient. Existing studies on post-intervention position changes have reported low incidences of bleeding and back pain, resulting in higher levels of patient comfort and satisfaction. These studies evaluated different angles of elevating the head of the bed and recommended further studies to evaluate the possibility of shifting patients to other positions after transfemoral cardiac interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

March 25, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2025

Completed
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

21 days

First QC Date

February 25, 2025

Last Update Submit

August 25, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Average Pain Score on Visual Analog Scale (VAS)

    Pain will be measured using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (severe pain). Higher scores indicate more severe pain.

    0 hour (baseline), 1st hour, 2nd hour, 3rd hour

  • Average Score on Immobilization Comfort Scale (ICS)

    Comfort during immobilization will be measured using the Immobilization Comfort Scale (ICS), a 20-item Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate greater comfort. Cronbach's alpha in this study ranged from 0.77 to 0.84.

    0 hour (baseline), 1st hour, 2nd hour, 3rd hour

  • Vascular Complication Score

    Vascular complications will be assessed using the Oozing and Bleeding Scale and the Ecchymosis and Hematoma Formation Scale developed by Elsaman (2022). Categories include: no bleeding/ecchymosis/hematoma, oozing/bleeding \<2 cm², bleeding ≥2 cm², ecchymosis \<2 cm², hematoma ≥2 cm². Higher scores indicate more severe vascular complications.

    0 hour (baseline), 1st hour, 2nd hour, 3rd hour

Study Arms (2)

back position group

EXPERIMENTAL

The bed levels of the patients in the experimental group changed the patient's position every 2 hours immediately after catheter removal and sandbag placement in the following order: supine position with a 15° head angle, semi-Fowler position with a 30° head angle, and lateral right or left position with a 15° head angle.

Other: The bed levels of the patients in the experimental group changed the patient's position

Control group

NO INTERVENTION

No intervention

Interventions

The bed levels of the patients in the experimental group changed the patient's position

back position group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years of age
  • Agree to participate in the study
  • Not undergoing emergency coronary angiography
  • Not consuming coffee or hypnotic drugs at least 12 hours ago
  • No history of chronic pain (e.g. arthritis)
  • Not addicted to alcohol or drugs
  • No psychological problems (such as depression, anxiety disorder)
  • Not using anxiolytics

You may not qualify if:

  • Not willing to participate in the study
  • Developing delirium during the follow-up period
  • Developing complications after coronary angiography (such as bleeding etc.)
  • Arrhythmia
  • Hemodynamic instability
  • Hereditary bleeding disorders
  • Platelet count less than 100,000/mm3
  • Abnormal coagulation parameters (high INR and/or aPTT)
  • History of percutaneous coronary intervention (PCI)
  • Multiple or bilateral punctures in the femoral artery
  • Presence of hematoma on arrival after the procedure
  • Radial access
  • Bleeding at the access site or at the access dressing site
  • Body mass index (BMI) ≥ 35 kg/m2
  • Back pain before treatment
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necibe

Kütahya, 43000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Peripheral Vascular DiseasesPain

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Burcu NAL, PhD

    Kütahya Health Sciences University, Faculty of Health Sciences

    STUDY DIRECTOR
  • Mehmet Ali ASTARCIOĞLU, Prof.

    Kütahya Health Sciences University, Faculty of Health Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients will be divided into experimental and control groups. Patients will know that they are participating in the study and the interventions that will be applied to them, but they will be blinded by not knowing which group they are in. The study data will be collected by a second researcher who is blinded to the groups. In the statistical analysis of the data, the groups will be labeled as group 1 and group 2, and the third researcher will be blinded when evaluating the results. Thus, the third researcher will be blinded to the study groups. In order to avoid bias in the evaluation of the results, the first researcher who is not blinded will not participate in any stage of the evaluation process.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is a double-blind randomized controlled trial planned to investigate the effect of position change after coronary angiography on pain, comfort and vascular complications.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Nursing

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 3, 2025

Study Start

March 25, 2025

Primary Completion

April 15, 2025

Study Completion

August 25, 2025

Last Updated

August 29, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations